Due to the specific activation of p-RIPK1 (Ser166) in cerebral ischemia, we suggest further studies to explore its feasibility as a biomarker for necroptosis and a potential therapeutic target for neuroprotection. The gene discussed is RIPK1; the disease is Cerebral ischemia.